Skip to content
10-Q

Quarterly Report

AMICUS THERAPEUTICS, INC.

0001178879-25-000011

← back to feed
Filed
Jul 31, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 25, 2025 308.24M sh
Shares Diluted Q2 2025 · Jun 30, 2025 308.25M sh
Shares Diluted Q2 2025 · Jun 30, 2025 307.97M sh
Shares Diluted Q2 2025 · Jun 30, 2024 303.77M sh
Shares Diluted Q2 2025 · Jun 30, 2024 303.34M sh
Capex Q2 2025 · Jun 30, 2025 $2.62M
Capex Q2 2025 · Jun 30, 2024 $2.91M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$18.77M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$7M
Long Term Debt Q2 2025 · Jun 30, 2025 $391.32M
Long Term Debt Q2 2025 · Dec 31, 2024 $390.11M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $158.7M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $213.75M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $209.34M
Stockholders Equity Q2 2025 · Jun 30, 2025 $204.3M
Stockholders Equity Q2 2025 · Mar 31, 2025 $193.56M
Stockholders Equity Q2 2025 · Dec 31, 2024 $194.05M
Stockholders Equity Q2 2025 · Jun 30, 2024 $132.52M
Stockholders Equity Q2 2025 · Mar 31, 2024 $130.69M
Stockholders Equity Q2 2025 · Dec 31, 2023 $160.17M
Current Liabilities Q2 2025 · Jun 30, 2025 $167.65M
Current Liabilities Q2 2025 · Dec 31, 2024 $148.7M
Total Liabilities Q2 2025 · Jun 30, 2025 $611M
Total Liabilities Q2 2025 · Dec 31, 2024 $590.99M
Current Assets Q2 2025 · Jun 30, 2025 $538.01M
Current Assets Q2 2025 · Dec 31, 2024 $504.74M
Total Assets Q2 2025 · Jun 30, 2025 $815.3M
Total Assets Q2 2025 · Dec 31, 2024 $785.03M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.08
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.15
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.05
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.21
Eps Basic Q2 2025 · Jun 30, 2025 −$0.08
Eps Basic Q2 2025 · Jun 30, 2025 −$0.15
Eps Basic Q2 2025 · Jun 30, 2024 −$0.05
Eps Basic Q2 2025 · Jun 30, 2024 −$0.21
Sga Expense Q2 2025 · Jun 30, 2025 $84.54M
Sga Expense Q2 2025 · Jun 30, 2025 $176.37M
Sga Expense Q2 2025 · Jun 30, 2024 $73.58M
Sga Expense Q2 2025 · Jun 30, 2024 $161.61M
Net Income Q2 2025 · Jun 30, 2025 −$24.42M
Net Income Q2 2025 · Jun 30, 2025 −$46.11M
Net Income Q2 2025 · Jun 30, 2024 −$15.7M
Net Income Q2 2025 · Jun 30, 2024 −$64.12M
Operating Income Q2 2025 · Jun 30, 2025 −$9.47M
Operating Income Q2 2025 · Jun 30, 2025 −$17.43M
Operating Income Q2 2025 · Jun 30, 2024 $14.97M
Operating Income Q2 2025 · Jun 30, 2024 −$12.75M
Gross Profit Q2 2025 · Jun 30, 2025 $139.47M
Gross Profit Q2 2025 · Jun 30, 2025 $253.02M
Gross Profit Q2 2025 · Jun 30, 2024 $115.41M
Gross Profit Q2 2025 · Jun 30, 2024 $212.24M
Revenue Q2 2025 · Jun 30, 2025 $154.69M
Revenue Q2 2025 · Jun 30, 2025 $279.94M
Revenue Q2 2025 · Jun 30, 2024 $126.67M
Revenue Q2 2025 · Jun 30, 2024 $237.07M